Table 5 E. coli pathotypes with drug resistance
PATHOTYPES (n) | CRO | TRM | GEN | AMP | CIP | AMC | TET | CHL | CAZ | MEM | NA |
|---|---|---|---|---|---|---|---|---|---|---|---|
EAEC (n= 21) | 4 (19.0%) | 13 (61.9%) | 3 (14.3%) | 12 (57.1%) | 10 (47.6%) | 4 (19.0%) | 16 (76.2%) | 3 (14.3%) | 4 (19.0%) | 0 (0.0%) | 6 (28.6%) |
EPEC/EAEC (n= 1) | 1 (100%) | 1 (100%) | 0 (0.0%) | 1 (100%) | 1 (100%) | 0 (0.0%) | 1 (100%) | 1 (100%) | 1 (100%) | 0 (0.0%) | 1 (100%) |
NMEC/UPEC (n= 41) | 16 (39.0%) | 37 (90.2%) | 21 (51.2%) | 39 (95.1%) | 37 (90.2%) | 6 (14.6%) | 36 (87.8%) | 1 (2.4%) | 16 (39.0%) | 1 (2.4%) | 37 (90.2%) |
NMEC/UPEC/DAEC (n= 25) | 18 (72.0%) | 23 (92.0%) | 16 (64.0%) | 25 (100%) | 20 (80.0%) | 14 (56.0%) | 19 (76.0%) | 1 (4.0%) | 18 (72.0%) | 0 (0.0%) | 20 (80.0%) |
NMEC/UPEC/EAEC (n= 36) | 17 (47.2%) | 30 (83.3%) | 6 (16.7%) | 34 (94.4%) | 27 (75.0%) | 8 (22.2%) | 30 (83.3%) | 10 (27.8%) | 17 (47.2%) | 1 (2.8%) | 26 (72.2%) |
NMEC/UPEC/EAEC/DAEC (n= 11) | 9 (81.8%) | 11 (100%) | 6 (54.5%) | 11 (100%) | 9 (81.8%) | 9 (81.8%) | 6 (54.5%) | 0 (0.0%) | 9 (81.8%) | 0 (0.0%) | 9 (81.8%) |
NMEC/UPEC/EAEC/EIEC (n= 1) | 1 (100%) | 1 (100%) | 0 (0.0%) | 1 (100%) | 1 (100%) | 0 (0.0%) | 1 (100%) | 0 (0.0%) | 1 (100%) | 0 (0.0%) | 1 (100%) |
UPEC (n=1) | 1 (100%) | 1 (100%) | 0 (0.0%) | 1 (100%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (100%) | 1 (100%) | 0 (0.0%) | 0 (0.0%) |
UPEC/EAEC/DAEC (n= 1) | 1 (100%) | 1 (100%) | 0 (0.0%) | 1 (100%) | 0 (0.0%) | 0 (0.0%) | 1 (100%) | 1 (100%) | 1 (100%) | 0 (0.0%) | 0 (0.0%) |
Total | 68 (48.9%) | 119 (85.6%) | 52 (37.4%) | 126 (90.6) | 105 (75.5%) | 41 (29.5%) | 110(79.1%) | 18 (12.9%) | 68 (48.9%) | 2 (1.4%) | 100 (71.9%) |